Zaid Chaudhry1, Evgeniy Kreydin2, Janine Oliver3, Shlomo Raz4. 1. AltaMed Health Services, El Monte, CA, USA. ZaidQChaudhry@gmail.com. 2. Catherine and Joseph Aresty Department of Urology, Keck School of Medicine of USC, Los Angeles, CA, USA. 3. Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA. 4. Division of Pelvic Medicine and Reconstructive Surgery, Department of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
Abstract
PURPOSE: To assess preoperative and perioperative characteristics associated with increased length of stay and major complications after mid-urethral sling mesh removal. METHODS: We performed an IRB-approved retrospective analysis of patients who underwent mid-urethral sling mesh removal. Demographic data and baseline surgical characteristics were collected. Operative reports and hospital/clinic notes were reviewed for complications which were categorized using the Clavien-Dindo Classification scheme. Length of stay was deemed abnormal if greater than 1 day. Complications were assessed using multivariate regression analysis. RESULTS: A total of 468 patients were identified as having undergone mid-urethral sling mesh removal. Mean age was 56 (± 11.1). 431 patients had either retropubic or transobturator slings. 241 patients underwent retropubic or groin exploration as a part of their mesh removal. A prolonged length of stay was noted in 73 patients (15.6%) and 13 patients (2.8%) experienced a Clavien Grade 3 complication. Pre-operative narcotic/benzodiazepine use, concomitant surgical procedure, bladder injury, increased ASA class, and major complications had an increased odds of a prolonged length of stay. Patients who experienced a bladder injury, groin/suprapubic incision, and estimated blood loss of over 400 mL had an increased odds of Clavien Grade 3 complications. CONCLUSIONS: Patient characteristics and perioperative factors are associated with increased length of stay and major complications after mid-urethral sling mesh removal.
PURPOSE: To assess preoperative and perioperative characteristics associated with increased length of stay and major complications after mid-urethral sling mesh removal. METHODS: We performed an IRB-approved retrospective analysis of patients who underwent mid-urethral sling mesh removal. Demographic data and baseline surgical characteristics were collected. Operative reports and hospital/clinic notes were reviewed for complications which were categorized using the Clavien-Dindo Classification scheme. Length of stay was deemed abnormal if greater than 1 day. Complications were assessed using multivariate regression analysis. RESULTS: A total of 468 patients were identified as having undergone mid-urethral sling mesh removal. Mean age was 56 (± 11.1). 431 patients had either retropubic or transobturator slings. 241 patients underwent retropubic or groin exploration as a part of their mesh removal. A prolonged length of stay was noted in 73 patients (15.6%) and 13 patients (2.8%) experienced a Clavien Grade 3 complication. Pre-operative narcotic/benzodiazepine use, concomitant surgical procedure, bladder injury, increased ASA class, and major complications had an increased odds of a prolonged length of stay. Patients who experienced a bladder injury, groin/suprapubic incision, and estimated blood loss of over 400 mL had an increased odds of Clavien Grade 3 complications. CONCLUSIONS: Patient characteristics and perioperative factors are associated with increased length of stay and major complications after mid-urethral sling mesh removal.
Authors: Emily M English; Sarah Bell; Neil S Kamdar; Carolyn W Swenson; Hallie Wiese; Daniel M Morgan Journal: Obstet Gynecol Date: 2019-04 Impact factor: 7.661
Authors: Orawee Chinthakanan; John R Miklos; Robert D Moore; Deborah R Karp; Gladys M Nogueiras; G Willy Davila Journal: Surg Technol Int Date: 2016-10-26
Authors: Ipek Gurol-Urganci; Rebecca S Geary; Jil B Mamza; Jonathan Duckett; Dina El-Hamamsy; Lucia Dolan; Douglas G Tincello; Jan van der Meulen Journal: JAMA Date: 2018-10-23 Impact factor: 56.272
Authors: Lisa Rogo-Gupta; Tamara Grisales; Linda Huynh; Larissa V Rodríguez; Shlomo Raz Journal: Female Pelvic Med Reconstr Surg Date: 2015 Nov-Dec Impact factor: 2.091